Biomaterials for Cancer Therapeutics Evolution and Innovation |
|
Editor:
| Park, Kinam |
Series title: | Woodhead Publishing Series in Biomaterials Ser. |
ISBN: | 978-0-08-102984-8 |
Publication Date: | Mar 2020 |
Publisher: | Elsevier Science & Technology
|
Imprint: | Woodhead Publishing Limited |
Book Format: | Ebook |
List Price: | Contact Supplier contact
Contact Supplier contact
Contact Supplier contact
|
Book Description:
|
Biomaterials for Cancer Therapeutics: Evolution and Innovation, Second Edition, discusses the role and potential of biomaterials in treating this prevalent disease. The first part of the book discusses the fundamentals of biomaterials for cancer therapeutics. Part Two discusses synthetic vaccines, proteins and polymers for cancer therapeutics. Part Three focuses on theranosis and drug delivery systems, while the final set of chapters look at biomaterial therapies and cancer...
More Description
Biomaterials for Cancer Therapeutics: Evolution and Innovation, Second Edition, discusses the role and potential of biomaterials in treating this prevalent disease. The first part of the book discusses the fundamentals of biomaterials for cancer therapeutics. Part Two discusses synthetic vaccines, proteins and polymers for cancer therapeutics. Part Three focuses on theranosis and drug delivery systems, while the final set of chapters look at biomaterial therapies and cancer cell interaction.
Cancer affects people of all ages, and approximately one in three people are estimated to be diagnosed with cancer during their lifetime. Extensive research is being undertaken by many different institutions to explore potential new therapeutics, and biomaterials technology is being developed to target, treat and prevent cancer. Hence, this book is a welcomed resource to the discussion.
- Provides a complete overview of the latest research into the potential of biomaterials for the diagnosis, treatment and prevention of cancer
- Discusses how the properties of specific biomaterials make them important in cancer treatment
- Covers synthetic vaccines, proteins and polymers for cancer therapeutics